PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy

por Cruz-Bermúdez, Alberto, Vicente-Blanco, Ramiro J., Laza-Briviesca, Raquel, García-Grande, Aránzazu, Laine-Menéndez, Sara, Gutiérrez, Lourdes, Calvo, Virginia, Romero, Atocha, Martín-Acosta, Paloma, García, José Miguel, Provencio, Mariano
Publicado 2017

Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I–IIIA NSCLC

por Garitaonaindia, Yago, Aguado-Noya, Ramón, Garcia-Grande, Aranzazu, Cordoba, Mar, Coronado Albi, Maria Jose, Campo Cañaveral, Jose Luis, Calvo, Virginia, Clemente, Mariola Blanco, Álvarez, Ruth, Peñas, Marta, Chara, Luis, Royuela, Ana, Provencio, Mariano
Publicado 2023

Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients

por Provencio, Mariano, Torrente, María, Calvo, Virginia, Pérez-Callejo, David, Gutiérrez, Lourdes, Franco, Fernando, Pérez-Barrios, Clara, Barquín, Miguel, Royuela, Ana, García-García, Francisco, Bueno, Coralia, Garcia-Grande, Aranzazu, Camps, Carlos, Massuti, Bartomeu, Sotomayor, Eduardo, Romero, Atocha
Publicado 2017

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients

por Provencio, Mariano, Pérez-Callejo, David, Torrente, María, Martin, Paloma, Calvo, Virginia, Gutiérrez, Lourdes, Franco, Fernando, Coronado, Maria José, Cruz-Bermúdez, Juan Luis, Ruiz-Valdepeñas, Asunción Martín, Cruz-Bermúdez, Alberto, Sánchez-Beato, Margarita, Romero, Atocha, García-Grande, Aránzazu
Publicado 2017

Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients

por Sánchez-Sanz, Alicia, García-Martín, Santiago, Sabín-Muñoz, Julia, Moreno-Torres, Irene, Elvira, Víctor, Al-Shahrour, Fátima, García-Grande, Aranzazu, Ramil, Elvira, Rodríguez-De la Fuente, Ofir, Brea-Álvarez, Beatriz, García-Hernández, Ruth, García-Merino, Antonio, Sánchez-López, Antonio José
Publicado 2023

Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study

por Moreno-Torres, Irene, González-García, Coral, Marconi, Marco, García-Grande, Aranzazu, Rodríguez-Esparragoza, Luis, Elvira, Víctor, Ramil, Elvira, Campos-Ruíz, Lucía, García-Hernández, Ruth, Al-Shahrour, Fátima, Fustero-Torre, Coral, Sánchez-Sanz, Alicia, García-Merino, Antonio, Sánchez López, Antonio José
Publicado 2018

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

por Sierra-Rodero, Belén, Cruz-Bermúdez, Alberto, Nadal, Ernest, Garitaonaindía, Yago, Insa, Amelia, Mosquera, Joaquín, Casal-Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodriguez-Abreu, Delvys, Martinez-Marti, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Laza-Briviesca, Raquel, Casarrubios, Marta, García-Grande, Aránzazu, Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

por Laza‐Briviesca, Raquel, Cruz‐Bermúdez, Alberto, Nadal, Ernest, Insa, Amelia, García‐Campelo, María del Rosario, Huidobro, Gerardo, Dómine, Manuel, Majem, Margarita, Rodríguez‐Abreu, Delvys, Martínez‐Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Casarrubios, Marta, Sierra‐Rodero, Belén, Tarín, Carlos, García‐Grande, Aránzazu, Haymaker, Cara, Wistuba, Ignacio I., Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021